{
  "id": 4600,
  "text": "</td><td>Conditional recommendation low-certainty evidence </td></tr><tr><td>13.WHO suggests that women from the general population who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AIS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VlA or co-testing, and, if negative, move to the recommended regular screening interval.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: </td><td>Conditional recommendation low-certainty evidence </td></tr><tr><td>13.WHO suggests that women from the general population who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AIS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VlA or co-testing, and, if negati\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据现有指南，女性在接受某些妇科治疗后，例如治疗过CIN2/3或原位腺癌（AIS）等病变，或者因为筛查呈阳性而接受治疗，建议在治疗后12个月进行HPV DNA检测。这种检测在条件允许时，会优先于细胞学检查或视觉检查或者联合测试。如果检测结果呈阴性，建议恢复到正常的定期筛查间隔。这一措施旨在确保治疗后的康复情况得到监测，并能够及时采取跟进措施，以预防疾病的复发或进展。",
  "query": "根据现有指南，女性在接受某些妇科治疗后，是否有推荐的后续检测方法来确保康复情况？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据现有指南，女性在接受某些妇科治疗后，是否有推荐的后续检测方法来确保康复情况？\n\n<reference text>: </td><td>Conditional recommendation low-certainty evidence </td></tr><tr><td>13.WHO suggests that women from the general population who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AIS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VlA or co-testing, and, if negative, move to the recommended regular screening interval.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据现有指南，女性在接受某些妇科治疗后，例如治疗过CIN2/3或原位腺癌（AIS）等病变，或者因为筛查呈阳性而接受治疗，建议在治疗后12个月进行HPV DNA检测。这种检测在条件允许时，会优先于细胞学检查或视觉检查或者联合测试。如果检测结果呈阴性，建议恢复到正常的定期筛查间隔。这一措施旨在确保治疗后的康复情况得到监测，并能够及时采取跟进措施，以预防疾病的复发或进展。"
}